TELVAS H 40/12.5 10'S

About

Telvas H 40/12.5 is a combination medication containing Telmisartan (an angiotensin II receptor blocker) and Hydrochlorothiazide (a thiazide diuretic). Telmisartan works by blocking the action of angiotensin II, a natural substance that narrows blood vessels, thereby relaxing them and lowering blood pressure. Hydrochlorothiazide complements this action by increasing the excretion of sodium and water from the body through the kidneys, which reduces blood volume and further decreases blood pressure. This dual mechanism provides effective and sustained control of hypertension.

This fixed-dose combination is prescribed for the treatment of essential hypertension, particularly in patients whose blood pressure is not adequately controlled with either Telmisartan or Hydrochlorothiazide alone. By combining these two agents, Telvas H 40/12.5 offers a comprehensive approach to blood pressure management, helping to reduce the overall risk of cardiovascular diseases such as stroke, heart attack, and kidney problems. Regular monitoring of blood pressure and electrolyte levels is important to ensure optimal therapeutic outcomes and patient safety.

Uses

• Treatment of essential hypertension
• When monotherapy is insufficient for blood pressure control
• Management of high blood pressure
• Reduction of cardiovascular risk in hypertensive patients

Directions For Use

Take this tablet orally once daily, with or without food, as prescribed by your doctor.

Benefits

• Provides effective and sustained blood pressure reduction
• Combines two distinct antihypertensive mechanisms
• Suitable for patients requiring combination therapy
• Reduces the risk of cardiovascular events
• Convenient once-daily dosing regimen
• Generally well-tolerated

Side Effects

• Dizziness
• Headache
• Fatigue
• Hypotension (low blood pressure)
• Electrolyte imbalances (e.g., hypokalemia, hyperkalemia)
• Nausea
• Diarrhea
• Muscle cramps
• Gout
• Renal dysfunction
• Cough (less common than with ACE inhibitors)
• Photosensitivity

Safety Measures

• Alcohol - Alcohol can intensify the blood pressure-lowering effect of this medication, potentially causing dizziness or lightheadedness. Avoid excessive alcohol intake.
• Pregnancy - Telvas H 40/12.5 is contraindicated during pregnancy, especially in the second and third trimesters, due to the risk of severe fetal harm or death.
• Breastfeeding - It is not recommended during breastfeeding as both active ingredients can pass into breast milk and may affect the nursing infant.
• Liver - Use with caution in patients with hepatic impairment. Hydrochlorothiazide can precipitate hepatic coma in severe liver disease.
• Kidney - Contraindicated in anuria. Use with caution in patients with severe renal impairment; close monitoring of kidney function and electrolytes is essential.
• Lung - While generally safe, Hydrochlorothiazide has been rarely associated with acute respiratory distress syndrome (ARDS). Monitor for any new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.